title: Regression of aggressive corneal vascularization after photodynamic therapy, subconjunctival Avastin injections and topical cyclosporin-A 1% drops: A case report.
abstract: We describe a case of significant regression of aggressive, deep and superficial corneal vascularization using photodynamic therapy (PDT) with verteporfin, repeated subconjunctival injections of Avastin®, plus topical cyclosporin-A 1% drops. The area of the corneal vascularization was treated with PDT with verteporfin. The subconjunctival space - next to the area of vascularization - was injected with Avastin® (1.25 mg/0.05 ml), immediately after PDT, and then for two more times during the follow-up period. The patient was kept on topical cyclosporin and prednisolone acetate. The outcome was evaluated clinically and photographically for 13 months. Corneal vascularization regressed significantly. No adverse effects were observed, neither locally or systemically. PDT with verteporfin, repeated subconjunctival injections of Avastin®, and topical cyclosporin-A drops appear to be safe and effective in treating aggressive corneal vascularization.
authors: Anterior Segment Division, King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia.
authors: Omar M
authors: OM
authors: Kirat
authors: Hassan A
authors: HA
authors: Al-Dhibi
keywords: Corneal vascularization; Photodynamic therapy (PDT); Subconjunctival Avastin®; Topical cyclosporin A; Verteporfin
references: J Ocul Pharmacol Ther. 1999 Oct;15(5):413-23
references: 10530702
references: Graefes Arch Clin Exp Ophthalmol. 2009 Oct;247(10):1375-82
references: 19415316
references: Ophthalmic Surg. 1986 Aug;17(8):502-8
references: 2427984
references: J Exp Med. 2001 Mar 5;193(5):607-20
references: 11238591
references: Klin Monbl Augenheilkd. 1972 May;160(5):554-9
references: 4561734
references: Cornea. 2009 May;28(4):468-70
references: 19411971
references: Indian J Ophthalmol. 1999 Mar;47(1):3-9
references: 16130277
references: Am J Ophthalmol. 2007 Sep;144(3):390-395
references: 17631268
references: Invest Ophthalmol Vis Sci. 1997 Feb;38(2):274-82
references: 9040459
references: Semin Ophthalmol. 2009 May-Jun;24(3):149-55
references: 19437350
references: Curr Eye Res. 2010 Jan;35(1):17-22
references: 20021250
references: Cornea. 2003 Jul;22(5):485-8
references: 12827058
references: Ophthalmologe. 2009 May;106(5):399-406
references: 19396447
references: Graefes Arch Clin Exp Ophthalmol. 2009 Dec;247(12):1701-6
references: 19680676
references: Curr Eye Res. 1995 Jan;14(1):1-10
references: 7720400
references: Invest Ophthalmol Vis Sci. 2000 Jul;41(8):2148-53
references: 10892856